Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
LNTH
Lantheus Holdings, Inc.
NASDAQ · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Last close
$99.53
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Market cap
$6.50B
Country
USA
RECENT INSIDER TRADES
2026-09-02
· Marshall Robert J. Jr.
(CFO and Treasurer)
· OTHER
2026-08-19
· Dinkelborg Ludger
(See Remarks)
· OTHER
2026-08-19
· Brown Kimberly
(Chief Accounting Officer)
· OTHER
2026-06-03
· Heino Mary Anne
(Executive Chair and CEO)
· OTHER
2026-06-03
· Ber Gerard
(Director)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
508
Shares held
107,938,182
Value
$9.68B
Percent of shares outstanding
165.37%
As of quarter end
2026-06-30
RECENT NEWS
Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)
Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer
Lantheus Holdings rallies on earnings, FDA approval and takeover interest
Lantheus gains approval of Bravnesta, generic competitor to Lutathera
FDA approves Lantheus’ BRAVNETSA
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Lantheus Holdings, Inc. (LNTH) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit